Although implantable cardioverter-defibrillators reduce death resulting from ventricular tachycardia (VT), episodes of VT decrease quality of life and predict increased rates of death. Antiarrhythmic drugs are often used to suppress VT but have potential adverse effects and relatively poor efficacy. In the largest study to date of catheter ablation for recurrent monomorphic VT caused by coronary artery disease, we prospectively evaluated radiofrequency catheter ablation using an irrigated catheter combined with an electroanatomic mapping system to facilitate substrate mapping during sinus rhythm. In contrast to prior studies, patients with hemodynamically unstable, unmappable VTs and multiple VTs were included because these VTs are often present in patients with ICDs. Despite a population with severely depressed ventricular function and drugrefractory, frequent VT, ablation abolished recurrent VT in approximately half of the patients. Of those in whom VT recurred, the frequency of episodes was substantially reduced for many, allowing reduction or withdrawal of antiarrhythmic drugs for some patients. The procedure mortality rate was 3%, and there were no strokes. The 1-year mortality rate was 18%, with ventricular arrhythmias and heart failure accounting for Ͼ70% of deaths. The present study demonstrates that patients with recurrent sustained VT and coronary artery disease are a high-risk population with substantial death risk despite implantable cardioverter-defibrillators. Catheter ablation is a reasonable option to reduce VT episodes, even if multiple and unmappable VTs are present. See p 2773.
Changes in Hospital Mortality Rates in 425 Patients With Acute ST-Elevation Myocardial Infarction and Cardiac Rupture Over a 30-Year Period
The incidence of cardiac rupture and its rate of death were investigated in 6678 consecutive ST-elevation myocardial infarction patients during a 30-year period (1977 to 2006) . A total of 425 patients experienced a free wall or septal rupture. After the exclusion of referrals from other centers (nϭ44), the incidence of definite cardiac rupture declined progressively (6.2% in 1977 to 1982 to 3.2% in 2001 to 2006) in parallel with a progressive use of reperfusion therapy (0% to 75.1%). In addition, among patients with cardiac rupture, there was a progressive fall in mortality rates (94% to 75%) in conjunction with a better control of systolic blood pressure; an increased use of reperfusion therapy (0% to 59%), ␤-blockers (0% to 45%), angiotensin-converting enzyme inhibitors (0% to 38%), and aspirin (0% to 96%); and a lower use of heparin (99% to 67%). Although cardiac rupture continues to be a frequent cause of death in ST-elevation myocardial infarction patients in the reperfusion era, our findings disclose that its incidence and rate of death have declined over the last 30 years. Although we recognized that the origin of this improvement is multifactorial, it is likely that it was associated in part with the progressive use of reperfusion therapy, particularly mechanical, and ␤-blockers, angiotensin-converting enzyme inhibitors, and aspirin. Thus, our results further stress the need for early implementation of these therapeutic measures that may potentially prevent mechanical complications, particularly in highrisk patients such as those with a first ST-elevation myocardial infarction, Ͼ60 years of age, without overt heart failure, and without ST-segment resolution. See p 2783.
Prevalence, Prognosis, and Implications of Isolated Minor Nonspecific ST-Segment and T-Wave Abnormalities in Older Adults: Cardiovascular Health Study
The prevalence and clinical significance of isolated minor nonspecific ST-segment and T-wave abnormalities (NSSTTAs; characterized by minor or upsloping ST-segment depression or T-wave flattening or inversion Ͻ1.0 mm) are poorly characterized in older adults. In the Cardiovascular Health Study, we observed that the prevalence of isolated NSSTTAs was 7.2% among those Ն65 years of age without major ECG abnormalities. The presence of isolated NSSTTAs was significantly associated with risk for all-cause mortality and especially coronary mortality (with nearly double the risk) but not nonfatal myocardial infarction. The association was independent of measures of subclinical atherosclerosis burden and left ventricular mass. In secondary analyses, isolated NSSTTAs appeared to be most strongly associated with primary arrhythmic death, suggesting that they may in part represent arrhythmogenic substrate. Whereas ECGs are not currently recommended as a routine screening measure, these data suggest that ECGs obtained for any clinical reason in older adults should be examined carefully for the presence of isolated NSSTTAs. More than 80% of coronary deaths occur in adults Ͼ65 years of age. Thus, physicians and patients could consider more intensive management of modifiable risk factors in those with isolated NSSTTAs to prevent fatal events. See p 2790.
Diagnostic-Therapeutic Cascade Revisited: Coronary Angiography, Coronary Artery Bypass Graft Surgery, and Percutaneous Coronary Intervention in the Modern Era
Wide variability exists in rates of coronary angiography, depending on geographic location. Although there is a strong relationship between rates of angiography and revascularization, the relationship is different depending on revascularization modality. With the geographic area as the unit of analysis, regression models indicate that coronary artery bypass rates are much less closely related to angiography rates than are percutaneous coronary intervention rates. In addition, there is a suggestion of a threshold effect for coronary artery bypass graft surgery in that areas with the highest angiography rates do no more coronary artery bypass graft surgeries than areas with more modest rates. Percutaneous coronary intervention rates, however, increase even at the very highest angiography rates. We conclude that, in very-high-rate areas, little or no additional serious coronary anatomy amenable to coronary artery bypass graft surgery is identified. Because routine use of percutaneous coronary intervention provides a known mortality and acute myocardial infarction prevention benefit only in patients with unstable coronary syndromes and because patients with unstable symptoms are likely to reach the catheterization laboratory no matter where they live, we are concerned that patients with a lower chance to benefit may be undergoing percutaneous coronary intervention in these areas of very high catheterization rates. See p 2797.
Sex Differences in Medical Care and Early Death After Acute Myocardial Infarction
Women receive less evidence-based medical care than men and had higher rates of death after acute myocardial infarction (AMI). It is unclear whether efforts undertaken to improve AMI care have mitigated these sex disparities in the current era. We therefore examined sex differences in care processes and in-hospital death among 78 254 patients with AMI from the Get With the GuidelinesCoronary Artery Disease database in 420 US hospitals from 2001 to 2006. Women were older, had more comorbidities, less often presented with ST-elevation myocardial infarction, and had higher unadjusted in-hospital mortality rates (8.2% versus 5.7%; PϽ0.0001) than men. After adjustment for baseline risk and clinical characteristics, sex-based differences in rates of death early after AMI were no longer observed overall but remained apparent in the ST-elevation myocardial infarction subpopulation (10.2% versus 5.5%; PϽ0.0001; adjusted odds ratioϭ1.12; 95% CI, 1.02 to 1.23) and were possibly accounted for by excess death among women in the initial 24 hours of hospitalization. Compared with men, women were also less likely to receive early aspirin and ␤-blocker treatments or reperfusion therapy or to achieve timely reperfusion. Women also experienced lower use of cardiac catheterization and revascularization procedures after AMI. This report confirms the notion that women still sustain higher adjusted mortality rates after ST-elevation myocardial infarction compared with men. Evidence of lower use of guidelines-based treatments and delayed reperfusion highlights the existing opportunities to improve the provision of healthcare among women hospitalized with AMI. Special attention should be given to those at highest risk, especially women with ST-elevation myocardial infarction during their early hospitalization period. See p 2803.
